Cholinergic Antagonists: all 1,354 studies that test it

Page 5 of 14. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.

• Meclizine as a Potential Smoking Cessation TreatmentCompletedNCT01443858Phase 2Results posted
• Optimal Dose of Succinylcholine and Rocuronium for Electroconvulsive Therapy (ECT)CompletedNCT01441960Not applicableResults posted
• Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01437540Phase 3Results posted
• Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01437397Phase 3Results posted
• Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01431287Phase 3Results posted
• Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01431274Phase 3Results posted
• Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPDCompletedNCT01387230Phase 3Results posted
• A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate AsthmaCompletedNCT01383499Phase 2Results posted
• Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract SymptomsCompletedNCT01381120Phase 4Results posted
• A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01372410Phase 2Results posted
• A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical ProstatectomyCompletedNCT01371994Phase 4Results posted
• Comparative Urine Proteomic Studies of Overactive Bladder in HumansCompletedNCT01367886Not applicableResults posted
• PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01350128Phase 2Results posted
• PT003 MDI Dose Confirmation StudyCompletedNCT01349816Phase 2Results posted
• PT003 MDI Cardiovascular Safety StudyCompletedNCT01349803Phase 2Results posted
• A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive BladderCompletedNCT01340027Phase 2Results posted
• An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study BCompletedNCT01323660Phase 3Results posted
• 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary DiseaseCompletedNCT01316913Phase 3Results posted
• Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent AsthmaCompletedNCT01316380Phase 3Results posted
• A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)CompletedNCT01314872Phase 2Results posted
• A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPDCompletedNCT01313637Phase 3Results posted
• A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)TerminatedNCT01312844Phase 2Results posted
• Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive BladderTerminatedNCT01302938Phase 4Results posted
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of FesoterodineCompletedNCT01302067Phase 4Results posted
• A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.CompletedNCT01302054Phase 4Results posted
• Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)CompletedNCT01290874Phase 3Results posted
• A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.TerminatedNCT01288079Phase 2Results posted
• This Is A Study Of Bioavailability And Food Effect For Fesoterodine.CompletedNCT01286454Phase 1Results posted
• Cocaine/Crack and Reduction of Compulsion With BiperidenCompletedNCT01251393Phase 3Results posted
• Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.CompletedNCT01233284Phase 2Results posted
• Nicotinic Modulation of the Default NetworkCompletedNCT01223404Not applicableResults posted
• Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)CompletedNCT01215721Not applicableResults posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.CompletedNCT01197508Phase 3Results posted
• Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic BladderCompletedNCT01192568Phase 4Results posted
• Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine SedationCompletedNCT01191398Not applicableResults posted
• Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent PainTerminatedNCT01189071Not applicableResults posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCompletedNCT01180400Phase 3Results posted
• Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) TrialCompletedNCT01178827Phase 4Results posted
• A Study to Assess the Cognitive Effects of Fesoterodine in Elderly SubjectsCompletedNCT01161472Phase 1Results posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)CompletedNCT01157078Phase 3Results posted
• Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy SubjectsCompletedNCT01155531Phase 1Results posted
• Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01154127Phase 3Results posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCompletedNCT01153347Phase 3Results posted
• A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCompletedNCT01152554Phase 3Results posted
• A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent AsthmaCompletedNCT01152450Phase 2Results posted
• Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseCompletedNCT01126437Phase 3Results posted
• A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental AbilityCompletedNCT01126424Phase 4Results posted
• Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate AsthmaCompletedNCT01122680Phase 2Results posted
• Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT01120093Phase 2Results posted
• Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01119950Phase 2Results posted
• Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese PatientsCompletedNCT01119937Phase 3Results posted
• Bronchodilator Responsiveness in Obliterative BronchiolitisCompletedNCT01112241Phase 4Results posted
• Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.CompletedNCT01093534Phase 4Results posted
• Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) DailyCompletedNCT01089751Phase 4Results posted
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01085045Phase 2Results posted
• Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol FumarateCompletedNCT01078623Phase 2Results posted
• Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary DiseaseCompletedNCT01072396Phase 4Results posted
• Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive BladderCompletedNCT01054222Phase 4Results posted
• Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and PlaceboCompletedNCT01049360Phase 2Results posted
• Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)CompletedNCT01045161Phase 3Results posted
• Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)CompletedNCT01044459Phase 3Results posted
• Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence PatientsCompletedNCT01042236Phase 2Results posted
• Topical Bethanechol for Improvement of Esophageal DysmotilityCompletedNCT01031043Phase 1Results posted
• 28-day Repeat Dose Study of GSK573719CompletedNCT01030965Phase 2Results posted
• Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow ParametersCompletedNCT01028014Not applicableResults posted
• Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract SymptomsCompletedNCT01021332Phase 3Results posted
• Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract SymptomsCompletedNCT01018511Phase 3Results posted
• Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's DiseaseCompletedNCT01018264Phase 4Results posted
• Effect of Indacaterol on Inspiratory Capacity (IC)CompletedNCT01012765Phase 3Results posted
• A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus PlaceboCompletedNCT01005901Phase 3Results posted
• Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01001494Phase 3Results posted
• Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory CapacityCompletedNCT00999908Phase 3Results posted
• Safety and Tolerability of Trospium Chloride and Metformin Hydrochloride in Healthy SubjectsCompletedNCT00986401Phase 1Results posted
• Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)CompletedNCT00970268Phase 3Results posted
• Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)CompletedNCT00939120Phase 4Results posted
• Trospium Chloride XR in Obese Female Patients With Overactive BladderCompletedNCT00932022Phase 4Results posted
• 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00929110Phase 3Results posted
• A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive BladderCompletedNCT00928070Phase 4Results posted
• Pediatric Elective Intubation With and Without Muscle Relaxation Utilizing the Shikani Optical StyletTerminatedNCT00912990Not applicableResults posted
• A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary UrgencyCompletedNCT00911937Phase 4Results posted
• Validation of a Real-time Urodynamic Measure of Urinary UrgencyCompletedNCT00909428Phase 4Results posted
• Study of Topically Administered Oxybutynin Gel in Patients With Urge IncontinenceCompletedNCT00909181Phase 3Results posted
• Study to Evaluate Single Inhaled Doses of PT001, PT003, PT005 and PT001 Plus PT005 in Healthy SubjectsCompletedNCT00893971Phase 1Results posted
• Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)CompletedNCT00891462Phase 3Results posted
• The Effects of Tiotropium on the Cough Reflex in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00870896Early Phase 1Results posted
• Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00868231Phase 2Results posted
• Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) TrialCompletedNCT00863551Phase 4Results posted
• Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES)CompletedNCT00862745Phase 4Results posted
• Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 YearsCompletedNCT00857896Phase 2Results posted
• A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00856193Phase 2Results posted
• Over Active Bladder Patients Having Sling SurgeryTerminatedNCT00852696Not applicableResults posted
• Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal TransitTerminatedNCT00832650Phase 1Results posted
• Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive BladderTerminatedNCT00821184Phase 3Results posted
• UK Study Assessing Flexible Dose Fesoterodine in AdultsCompletedNCT00806494Phase 4Results posted
• A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.CompletedNCT00798434Phase 4Results posted
• Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)CompletedNCT00780403Phase 4Results posted
• Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)CompletedNCT00779116Phase 4Results posted
• Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)CompletedNCT00776984Phase 3Results posted
• Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)CompletedNCT00772538Phase 3Results posted
• A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)CompletedNCT00768521Phase 1Results posted

← Cholinergic Antagonists overview